Improved rapid molecular diagnosis of multidrug-resistant tuberculosis using a new reverse hybridization assay, REBA MTB-MDR

Hyeeun Bang, Sangjung Park, Joohwan Hwang, Hyunwoo Jin, Eunjin Cho, Dae Yoon Kim, Taeksun Song, Isdore Chola Shamputa, Laura E. Via, Clifton E. Barry, Sangnae Cho, Hyeyoung Lee

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Rapid diagnosis of multidrug-resistant tuberculosis (MDR-TB) is essential for the prompt initiation of effective second-line therapy to improve treatment outcome and limit transmission of this obstinate disease. A variety of molecular methods that enable the rapid detection of mutations implicated in MDR-TB have been developed. The sensitivity of the methods is dependent, in principle, on the repertoire of mutations being detected, which is typically limited to mutations in the genes rpoB, katG and the promoter region of inhA. In this study, a new reverse hybridization assay, REBA MTB-MDR (M&D), that probes mutations in the oxyR-ahpC intergenic region, in addition to those in rpoB, katG and the inhA promoter region, was evaluated. A set of 240 Mycobacterium tuberculosis clinical isolates from patients receiving retreatment regimens was subjected to conventional phenotypic drug-susceptibility testing (DST) and the REBA MTB-MDR assay. The nucleotide sequences of the loci known to be involved in drug resistance were determined for comparison. In brief, the results showed that the REBA MTB-MDR assay efficiently recognized nucleotide changes in the oxyR-ahpC intergenic region as well as those in rpoB, katG and the inhA promoter region with higher sensitivity, resulting in an 81.0% detection rate for isoniazid resistance. Inclusion of the oxyR-ahpC intergenic region in the REBA MTB-MDR assay improved the overall sensitivity of molecular DST for MDR-TB from 73.1 to 79.9 %.

Original languageEnglish
Pages (from-to)1447-1454
Number of pages8
JournalJournal of Medical Microbiology
Volume60
Issue number10
DOIs
Publication statusPublished - 2011 Oct 1

Fingerprint

Multidrug-Resistant Tuberculosis
Intergenic DNA
Genetic Promoter Regions
Mutation
Retreatment
Isoniazid
Mycobacterium tuberculosis
Drug Resistance
Pharmaceutical Preparations
Nucleotides
Genes
Therapeutics

All Science Journal Classification (ASJC) codes

  • Microbiology
  • Microbiology (medical)

Cite this

Bang, Hyeeun ; Park, Sangjung ; Hwang, Joohwan ; Jin, Hyunwoo ; Cho, Eunjin ; Kim, Dae Yoon ; Song, Taeksun ; Shamputa, Isdore Chola ; Via, Laura E. ; Barry, Clifton E. ; Cho, Sangnae ; Lee, Hyeyoung. / Improved rapid molecular diagnosis of multidrug-resistant tuberculosis using a new reverse hybridization assay, REBA MTB-MDR. In: Journal of Medical Microbiology. 2011 ; Vol. 60, No. 10. pp. 1447-1454.
@article{ee76aab827114cf88ed95bc167b8c200,
title = "Improved rapid molecular diagnosis of multidrug-resistant tuberculosis using a new reverse hybridization assay, REBA MTB-MDR",
abstract = "Rapid diagnosis of multidrug-resistant tuberculosis (MDR-TB) is essential for the prompt initiation of effective second-line therapy to improve treatment outcome and limit transmission of this obstinate disease. A variety of molecular methods that enable the rapid detection of mutations implicated in MDR-TB have been developed. The sensitivity of the methods is dependent, in principle, on the repertoire of mutations being detected, which is typically limited to mutations in the genes rpoB, katG and the promoter region of inhA. In this study, a new reverse hybridization assay, REBA MTB-MDR (M&D), that probes mutations in the oxyR-ahpC intergenic region, in addition to those in rpoB, katG and the inhA promoter region, was evaluated. A set of 240 Mycobacterium tuberculosis clinical isolates from patients receiving retreatment regimens was subjected to conventional phenotypic drug-susceptibility testing (DST) and the REBA MTB-MDR assay. The nucleotide sequences of the loci known to be involved in drug resistance were determined for comparison. In brief, the results showed that the REBA MTB-MDR assay efficiently recognized nucleotide changes in the oxyR-ahpC intergenic region as well as those in rpoB, katG and the inhA promoter region with higher sensitivity, resulting in an 81.0{\%} detection rate for isoniazid resistance. Inclusion of the oxyR-ahpC intergenic region in the REBA MTB-MDR assay improved the overall sensitivity of molecular DST for MDR-TB from 73.1 to 79.9 {\%}.",
author = "Hyeeun Bang and Sangjung Park and Joohwan Hwang and Hyunwoo Jin and Eunjin Cho and Kim, {Dae Yoon} and Taeksun Song and Shamputa, {Isdore Chola} and Via, {Laura E.} and Barry, {Clifton E.} and Sangnae Cho and Hyeyoung Lee",
year = "2011",
month = "10",
day = "1",
doi = "10.1099/jmm.0.032292-0",
language = "English",
volume = "60",
pages = "1447--1454",
journal = "Journal of Medical Microbiology",
issn = "0022-2615",
publisher = "Society for General Microbiology",
number = "10",

}

Improved rapid molecular diagnosis of multidrug-resistant tuberculosis using a new reverse hybridization assay, REBA MTB-MDR. / Bang, Hyeeun; Park, Sangjung; Hwang, Joohwan; Jin, Hyunwoo; Cho, Eunjin; Kim, Dae Yoon; Song, Taeksun; Shamputa, Isdore Chola; Via, Laura E.; Barry, Clifton E.; Cho, Sangnae; Lee, Hyeyoung.

In: Journal of Medical Microbiology, Vol. 60, No. 10, 01.10.2011, p. 1447-1454.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Improved rapid molecular diagnosis of multidrug-resistant tuberculosis using a new reverse hybridization assay, REBA MTB-MDR

AU - Bang, Hyeeun

AU - Park, Sangjung

AU - Hwang, Joohwan

AU - Jin, Hyunwoo

AU - Cho, Eunjin

AU - Kim, Dae Yoon

AU - Song, Taeksun

AU - Shamputa, Isdore Chola

AU - Via, Laura E.

AU - Barry, Clifton E.

AU - Cho, Sangnae

AU - Lee, Hyeyoung

PY - 2011/10/1

Y1 - 2011/10/1

N2 - Rapid diagnosis of multidrug-resistant tuberculosis (MDR-TB) is essential for the prompt initiation of effective second-line therapy to improve treatment outcome and limit transmission of this obstinate disease. A variety of molecular methods that enable the rapid detection of mutations implicated in MDR-TB have been developed. The sensitivity of the methods is dependent, in principle, on the repertoire of mutations being detected, which is typically limited to mutations in the genes rpoB, katG and the promoter region of inhA. In this study, a new reverse hybridization assay, REBA MTB-MDR (M&D), that probes mutations in the oxyR-ahpC intergenic region, in addition to those in rpoB, katG and the inhA promoter region, was evaluated. A set of 240 Mycobacterium tuberculosis clinical isolates from patients receiving retreatment regimens was subjected to conventional phenotypic drug-susceptibility testing (DST) and the REBA MTB-MDR assay. The nucleotide sequences of the loci known to be involved in drug resistance were determined for comparison. In brief, the results showed that the REBA MTB-MDR assay efficiently recognized nucleotide changes in the oxyR-ahpC intergenic region as well as those in rpoB, katG and the inhA promoter region with higher sensitivity, resulting in an 81.0% detection rate for isoniazid resistance. Inclusion of the oxyR-ahpC intergenic region in the REBA MTB-MDR assay improved the overall sensitivity of molecular DST for MDR-TB from 73.1 to 79.9 %.

AB - Rapid diagnosis of multidrug-resistant tuberculosis (MDR-TB) is essential for the prompt initiation of effective second-line therapy to improve treatment outcome and limit transmission of this obstinate disease. A variety of molecular methods that enable the rapid detection of mutations implicated in MDR-TB have been developed. The sensitivity of the methods is dependent, in principle, on the repertoire of mutations being detected, which is typically limited to mutations in the genes rpoB, katG and the promoter region of inhA. In this study, a new reverse hybridization assay, REBA MTB-MDR (M&D), that probes mutations in the oxyR-ahpC intergenic region, in addition to those in rpoB, katG and the inhA promoter region, was evaluated. A set of 240 Mycobacterium tuberculosis clinical isolates from patients receiving retreatment regimens was subjected to conventional phenotypic drug-susceptibility testing (DST) and the REBA MTB-MDR assay. The nucleotide sequences of the loci known to be involved in drug resistance were determined for comparison. In brief, the results showed that the REBA MTB-MDR assay efficiently recognized nucleotide changes in the oxyR-ahpC intergenic region as well as those in rpoB, katG and the inhA promoter region with higher sensitivity, resulting in an 81.0% detection rate for isoniazid resistance. Inclusion of the oxyR-ahpC intergenic region in the REBA MTB-MDR assay improved the overall sensitivity of molecular DST for MDR-TB from 73.1 to 79.9 %.

UR - http://www.scopus.com/inward/record.url?scp=80053165969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053165969&partnerID=8YFLogxK

U2 - 10.1099/jmm.0.032292-0

DO - 10.1099/jmm.0.032292-0

M3 - Article

VL - 60

SP - 1447

EP - 1454

JO - Journal of Medical Microbiology

JF - Journal of Medical Microbiology

SN - 0022-2615

IS - 10

ER -